BlackRock, Inc. 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 670,035 2.100% | -1,534,474 (-69.61%) | Filing |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 2,204,509 7.200% | 735,550 (+50.07%) | Filing |
| 2020-02-10 2:19 pm Sale | 2020-01-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 1,468,959 4.960% | -37,695 (-2.50%) | Filing |
| 2020-02-05 11:26 am Sale | 2019-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BlackRock Inc. BLK | 1,506,654 6.300% | -193,831 (-11.40%) | Filing |